nodes	percent_of_prediction	percent_of_DWPC	metapath
Gemifloxacin—Gastritis—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Pain—Cisplatin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Dermatitis—Bleomycin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Alanine aminotransferase increased—Doxorubicin—testicular cancer	0.00114	0.00114	CcSEcCtD
Gemifloxacin—Renal failure—Methotrexate—testicular cancer	0.00113	0.00113	CcSEcCtD
Gemifloxacin—Stomatitis—Methotrexate—testicular cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Dysphagia—Doxorubicin—testicular cancer	0.00112	0.00112	CcSEcCtD
Gemifloxacin—Asthenia—Ifosfamide—testicular cancer	0.00111	0.00111	CcSEcCtD
Gemifloxacin—Eosinophilia—Doxorubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Epirubicin—testicular cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Pruritus—Ifosfamide—testicular cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Haematuria—Methotrexate—testicular cancer	0.0011	0.0011	CcSEcCtD
Gemifloxacin—Pancreatitis—Doxorubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Dyspnoea—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Epirubicin—testicular cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Somnolence—Etoposide—testicular cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Methotrexate—testicular cancer	0.00109	0.00109	CcSEcCtD
Gemifloxacin—Pneumonia—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Nausea—Bleomycin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Infestation NOS—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Infestation—Epirubicin—testicular cancer	0.00108	0.00108	CcSEcCtD
Gemifloxacin—Vomiting—Dactinomycin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Agranulocytosis—Methotrexate—testicular cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Rash—Dactinomycin—testicular cancer	0.00107	0.00107	CcSEcCtD
Gemifloxacin—Decreased appetite—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Diarrhoea—Ifosfamide—testicular cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Renal failure—Epirubicin—testicular cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Etoposide—testicular cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Body temperature increased—Cisplatin—testicular cancer	0.00106	0.00106	CcSEcCtD
Gemifloxacin—Fatigue—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Stomatitis—Epirubicin—testicular cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Pain—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Constipation—Etoposide—testicular cancer	0.00105	0.00105	CcSEcCtD
Gemifloxacin—Haemoglobin—Methotrexate—testicular cancer	0.00104	0.00104	CcSEcCtD
Gemifloxacin—Haemorrhage—Methotrexate—testicular cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Haematuria—Epirubicin—testicular cancer	0.00103	0.00103	CcSEcCtD
Gemifloxacin—Dizziness—Ifosfamide—testicular cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Pharyngitis—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Methotrexate—testicular cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Photosensitivity reaction—Doxorubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Epirubicin—testicular cancer	0.00102	0.00102	CcSEcCtD
Gemifloxacin—Urethral disorder—Methotrexate—testicular cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Hyperglycaemia—Doxorubicin—testicular cancer	0.00101	0.00101	CcSEcCtD
Gemifloxacin—Nausea—Dactinomycin—testicular cancer	0.001	0.001	CcSEcCtD
Gemifloxacin—Agranulocytosis—Epirubicin—testicular cancer	0.001	0.001	CcSEcCtD
Gemifloxacin—Pneumonia—Doxorubicin—testicular cancer	0.001	0.001	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Etoposide—testicular cancer	0.001	0.001	CcSEcCtD
Gemifloxacin—Infestation NOS—Doxorubicin—testicular cancer	0.000995	0.000995	CcSEcCtD
Gemifloxacin—Infestation—Doxorubicin—testicular cancer	0.000995	0.000995	CcSEcCtD
Gemifloxacin—Visual impairment—Methotrexate—testicular cancer	0.000994	0.000994	CcSEcCtD
Gemifloxacin—Vomiting—Ifosfamide—testicular cancer	0.000985	0.000985	CcSEcCtD
Gemifloxacin—Renal failure—Doxorubicin—testicular cancer	0.000978	0.000978	CcSEcCtD
Gemifloxacin—Rash—Ifosfamide—testicular cancer	0.000977	0.000977	CcSEcCtD
Gemifloxacin—Dermatitis—Ifosfamide—testicular cancer	0.000976	0.000976	CcSEcCtD
Gemifloxacin—Erythema multiforme—Methotrexate—testicular cancer	0.000975	0.000975	CcSEcCtD
Gemifloxacin—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000975	0.000975	CcSEcCtD
Gemifloxacin—Urticaria—Etoposide—testicular cancer	0.000972	0.000972	CcSEcCtD
Gemifloxacin—Haemoglobin—Epirubicin—testicular cancer	0.00097	0.00097	CcSEcCtD
Gemifloxacin—Stomatitis—Doxorubicin—testicular cancer	0.00097	0.00097	CcSEcCtD
Gemifloxacin—Abdominal pain—Etoposide—testicular cancer	0.000967	0.000967	CcSEcCtD
Gemifloxacin—Body temperature increased—Etoposide—testicular cancer	0.000967	0.000967	CcSEcCtD
Gemifloxacin—Haemorrhage—Epirubicin—testicular cancer	0.000965	0.000965	CcSEcCtD
Gemifloxacin—Eye disorder—Methotrexate—testicular cancer	0.000964	0.000964	CcSEcCtD
Gemifloxacin—Asthenia—Cisplatin—testicular cancer	0.000958	0.000958	CcSEcCtD
Gemifloxacin—Pharyngitis—Epirubicin—testicular cancer	0.000958	0.000958	CcSEcCtD
Gemifloxacin—Cardiac disorder—Methotrexate—testicular cancer	0.000957	0.000957	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Epirubicin—testicular cancer	0.000953	0.000953	CcSEcCtD
Gemifloxacin—Oedema peripheral—Epirubicin—testicular cancer	0.000951	0.000951	CcSEcCtD
Gemifloxacin—Haematuria—Doxorubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Epirubicin—testicular cancer	0.000949	0.000949	CcSEcCtD
Gemifloxacin—Urethral disorder—Epirubicin—testicular cancer	0.000946	0.000946	CcSEcCtD
Gemifloxacin—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000941	0.000941	CcSEcCtD
Gemifloxacin—Angiopathy—Methotrexate—testicular cancer	0.000936	0.000936	CcSEcCtD
Gemifloxacin—Immune system disorder—Methotrexate—testicular cancer	0.000932	0.000932	CcSEcCtD
Gemifloxacin—Visual impairment—Epirubicin—testicular cancer	0.00093	0.00093	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Methotrexate—testicular cancer	0.00093	0.00093	CcSEcCtD
Gemifloxacin—Agranulocytosis—Doxorubicin—testicular cancer	0.000929	0.000929	CcSEcCtD
Gemifloxacin—Nausea—Ifosfamide—testicular cancer	0.00092	0.00092	CcSEcCtD
Gemifloxacin—Diarrhoea—Cisplatin—testicular cancer	0.000914	0.000914	CcSEcCtD
Gemifloxacin—Erythema multiforme—Epirubicin—testicular cancer	0.000913	0.000913	CcSEcCtD
Gemifloxacin—Mental disorder—Methotrexate—testicular cancer	0.000904	0.000904	CcSEcCtD
Gemifloxacin—Eye disorder—Epirubicin—testicular cancer	0.000902	0.000902	CcSEcCtD
Gemifloxacin—Haemoglobin—Doxorubicin—testicular cancer	0.000898	0.000898	CcSEcCtD
Gemifloxacin—Flushing—Epirubicin—testicular cancer	0.000896	0.000896	CcSEcCtD
Gemifloxacin—Cardiac disorder—Epirubicin—testicular cancer	0.000896	0.000896	CcSEcCtD
Gemifloxacin—Haemorrhage—Doxorubicin—testicular cancer	0.000893	0.000893	CcSEcCtD
Gemifloxacin—Pharyngitis—Doxorubicin—testicular cancer	0.000886	0.000886	CcSEcCtD
Gemifloxacin—Urinary tract disorder—Doxorubicin—testicular cancer	0.000882	0.000882	CcSEcCtD
Gemifloxacin—Oedema peripheral—Doxorubicin—testicular cancer	0.00088	0.00088	CcSEcCtD
Gemifloxacin—Dysgeusia—Methotrexate—testicular cancer	0.000879	0.000879	CcSEcCtD
Gemifloxacin—Asthenia—Etoposide—testicular cancer	0.000878	0.000878	CcSEcCtD
Gemifloxacin—Connective tissue disorder—Doxorubicin—testicular cancer	0.000878	0.000878	CcSEcCtD
Gemifloxacin—Angiopathy—Epirubicin—testicular cancer	0.000876	0.000876	CcSEcCtD
Gemifloxacin—Urethral disorder—Doxorubicin—testicular cancer	0.000876	0.000876	CcSEcCtD
Gemifloxacin—Immune system disorder—Epirubicin—testicular cancer	0.000872	0.000872	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Epirubicin—testicular cancer	0.00087	0.00087	CcSEcCtD
Gemifloxacin—Back pain—Methotrexate—testicular cancer	0.000869	0.000869	CcSEcCtD
Gemifloxacin—Pruritus—Etoposide—testicular cancer	0.000866	0.000866	CcSEcCtD
Gemifloxacin—Visual impairment—Doxorubicin—testicular cancer	0.000861	0.000861	CcSEcCtD
Gemifloxacin—Vomiting—Cisplatin—testicular cancer	0.000849	0.000849	CcSEcCtD
Gemifloxacin—Mental disorder—Epirubicin—testicular cancer	0.000846	0.000846	CcSEcCtD
Gemifloxacin—Erythema multiforme—Doxorubicin—testicular cancer	0.000845	0.000845	CcSEcCtD
Gemifloxacin—Rash—Cisplatin—testicular cancer	0.000842	0.000842	CcSEcCtD
Gemifloxacin—Dermatitis—Cisplatin—testicular cancer	0.000841	0.000841	CcSEcCtD
Gemifloxacin—Diarrhoea—Etoposide—testicular cancer	0.000837	0.000837	CcSEcCtD
Gemifloxacin—Eye disorder—Doxorubicin—testicular cancer	0.000835	0.000835	CcSEcCtD
Gemifloxacin—Anaemia—Methotrexate—testicular cancer	0.00083	0.00083	CcSEcCtD
Gemifloxacin—Flushing—Doxorubicin—testicular cancer	0.000829	0.000829	CcSEcCtD
Gemifloxacin—Cardiac disorder—Doxorubicin—testicular cancer	0.000829	0.000829	CcSEcCtD
Gemifloxacin—Flatulence—Epirubicin—testicular cancer	0.000828	0.000828	CcSEcCtD
Gemifloxacin—Tension—Epirubicin—testicular cancer	0.000825	0.000825	CcSEcCtD
Gemifloxacin—Dysgeusia—Epirubicin—testicular cancer	0.000823	0.000823	CcSEcCtD
Gemifloxacin—Nervousness—Epirubicin—testicular cancer	0.000816	0.000816	CcSEcCtD
Gemifloxacin—Back pain—Epirubicin—testicular cancer	0.000813	0.000813	CcSEcCtD
Gemifloxacin—Angiopathy—Doxorubicin—testicular cancer	0.00081	0.00081	CcSEcCtD
Gemifloxacin—Dizziness—Etoposide—testicular cancer	0.000809	0.000809	CcSEcCtD
Gemifloxacin—Muscle spasms—Epirubicin—testicular cancer	0.000808	0.000808	CcSEcCtD
Gemifloxacin—Immune system disorder—Doxorubicin—testicular cancer	0.000807	0.000807	CcSEcCtD
Gemifloxacin—Vertigo—Methotrexate—testicular cancer	0.000807	0.000807	CcSEcCtD
Gemifloxacin—Mediastinal disorder—Doxorubicin—testicular cancer	0.000805	0.000805	CcSEcCtD
Gemifloxacin—Leukopenia—Methotrexate—testicular cancer	0.000804	0.000804	CcSEcCtD
Gemifloxacin—Nausea—Cisplatin—testicular cancer	0.000793	0.000793	CcSEcCtD
Gemifloxacin—Mental disorder—Doxorubicin—testicular cancer	0.000783	0.000783	CcSEcCtD
Gemifloxacin—Vomiting—Etoposide—testicular cancer	0.000778	0.000778	CcSEcCtD
Gemifloxacin—Anaemia—Epirubicin—testicular cancer	0.000777	0.000777	CcSEcCtD
Gemifloxacin—Rash—Etoposide—testicular cancer	0.000771	0.000771	CcSEcCtD
Gemifloxacin—Dermatitis—Etoposide—testicular cancer	0.000771	0.000771	CcSEcCtD
Gemifloxacin—Headache—Etoposide—testicular cancer	0.000766	0.000766	CcSEcCtD
Gemifloxacin—Flatulence—Doxorubicin—testicular cancer	0.000766	0.000766	CcSEcCtD
Gemifloxacin—Myalgia—Methotrexate—testicular cancer	0.000764	0.000764	CcSEcCtD
Gemifloxacin—Arthralgia—Methotrexate—testicular cancer	0.000764	0.000764	CcSEcCtD
Gemifloxacin—Tension—Doxorubicin—testicular cancer	0.000763	0.000763	CcSEcCtD
Gemifloxacin—Dysgeusia—Doxorubicin—testicular cancer	0.000761	0.000761	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000759	0.000759	CcSEcCtD
Gemifloxacin—Nervousness—Doxorubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Gemifloxacin—Vertigo—Epirubicin—testicular cancer	0.000755	0.000755	CcSEcCtD
Gemifloxacin—Syncope—Epirubicin—testicular cancer	0.000754	0.000754	CcSEcCtD
Gemifloxacin—Leukopenia—Epirubicin—testicular cancer	0.000752	0.000752	CcSEcCtD
Gemifloxacin—Back pain—Doxorubicin—testicular cancer	0.000752	0.000752	CcSEcCtD
Gemifloxacin—Muscle spasms—Doxorubicin—testicular cancer	0.000748	0.000748	CcSEcCtD
Gemifloxacin—Palpitations—Epirubicin—testicular cancer	0.000743	0.000743	CcSEcCtD
Gemifloxacin—Loss of consciousness—Epirubicin—testicular cancer	0.000739	0.000739	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Methotrexate—testicular cancer	0.000733	0.000733	CcSEcCtD
Gemifloxacin—Nausea—Etoposide—testicular cancer	0.000727	0.000727	CcSEcCtD
Gemifloxacin—Nervous system disorder—Methotrexate—testicular cancer	0.000719	0.000719	CcSEcCtD
Gemifloxacin—Anaemia—Doxorubicin—testicular cancer	0.000719	0.000719	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Methotrexate—testicular cancer	0.000718	0.000718	CcSEcCtD
Gemifloxacin—Myalgia—Epirubicin—testicular cancer	0.000715	0.000715	CcSEcCtD
Gemifloxacin—Arthralgia—Epirubicin—testicular cancer	0.000715	0.000715	CcSEcCtD
Gemifloxacin—Skin disorder—Methotrexate—testicular cancer	0.000712	0.000712	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00071	0.00071	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Methotrexate—testicular cancer	0.000708	0.000708	CcSEcCtD
Gemifloxacin—Dry mouth—Epirubicin—testicular cancer	0.0007	0.0007	CcSEcCtD
Gemifloxacin—Vertigo—Doxorubicin—testicular cancer	0.000699	0.000699	CcSEcCtD
Gemifloxacin—Anorexia—Methotrexate—testicular cancer	0.000699	0.000699	CcSEcCtD
Gemifloxacin—Syncope—Doxorubicin—testicular cancer	0.000697	0.000697	CcSEcCtD
Gemifloxacin—Leukopenia—Doxorubicin—testicular cancer	0.000696	0.000696	CcSEcCtD
Gemifloxacin—Palpitations—Doxorubicin—testicular cancer	0.000687	0.000687	CcSEcCtD
Gemifloxacin—Oedema—Epirubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Epirubicin—testicular cancer	0.000686	0.000686	CcSEcCtD
Gemifloxacin—Loss of consciousness—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Gemifloxacin—Shock—Epirubicin—testicular cancer	0.000675	0.000675	CcSEcCtD
Gemifloxacin—Nervous system disorder—Epirubicin—testicular cancer	0.000673	0.000673	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Epirubicin—testicular cancer	0.000671	0.000671	CcSEcCtD
Gemifloxacin—Tachycardia—Epirubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000668	0.000668	CcSEcCtD
Gemifloxacin—Skin disorder—Epirubicin—testicular cancer	0.000666	0.000666	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Epirubicin—testicular cancer	0.000663	0.000663	CcSEcCtD
Gemifloxacin—Insomnia—Methotrexate—testicular cancer	0.000663	0.000663	CcSEcCtD
Gemifloxacin—Arthralgia—Doxorubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Gemifloxacin—Myalgia—Doxorubicin—testicular cancer	0.000662	0.000662	CcSEcCtD
Gemifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000657	0.000657	CcSEcCtD
Gemifloxacin—Anorexia—Epirubicin—testicular cancer	0.000654	0.000654	CcSEcCtD
Gemifloxacin—Dyspnoea—Methotrexate—testicular cancer	0.000653	0.000653	CcSEcCtD
Gemifloxacin—Somnolence—Methotrexate—testicular cancer	0.000652	0.000652	CcSEcCtD
Gemifloxacin—Dry mouth—Doxorubicin—testicular cancer	0.000647	0.000647	CcSEcCtD
Gemifloxacin—Dyspepsia—Methotrexate—testicular cancer	0.000645	0.000645	CcSEcCtD
Gemifloxacin—Decreased appetite—Methotrexate—testicular cancer	0.000637	0.000637	CcSEcCtD
Gemifloxacin—Oedema—Doxorubicin—testicular cancer	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Anaphylactic shock—Doxorubicin—testicular cancer	0.000635	0.000635	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000633	0.000633	CcSEcCtD
Gemifloxacin—Fatigue—Methotrexate—testicular cancer	0.000632	0.000632	CcSEcCtD
Gemifloxacin—Pain—Methotrexate—testicular cancer	0.000627	0.000627	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000625	0.000625	CcSEcCtD
Gemifloxacin—Shock—Doxorubicin—testicular cancer	0.000624	0.000624	CcSEcCtD
Gemifloxacin—Nervous system disorder—Doxorubicin—testicular cancer	0.000622	0.000622	CcSEcCtD
Gemifloxacin—Thrombocytopenia—Doxorubicin—testicular cancer	0.000621	0.000621	CcSEcCtD
Gemifloxacin—Insomnia—Epirubicin—testicular cancer	0.00062	0.00062	CcSEcCtD
Gemifloxacin—Tachycardia—Doxorubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Gemifloxacin—Skin disorder—Doxorubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Gemifloxacin—Hyperhidrosis—Doxorubicin—testicular cancer	0.000613	0.000613	CcSEcCtD
Gemifloxacin—Dyspnoea—Epirubicin—testicular cancer	0.000611	0.000611	CcSEcCtD
Gemifloxacin—Somnolence—Epirubicin—testicular cancer	0.00061	0.00061	CcSEcCtD
Gemifloxacin—Anorexia—Doxorubicin—testicular cancer	0.000605	0.000605	CcSEcCtD
Gemifloxacin—Dyspepsia—Epirubicin—testicular cancer	0.000604	0.000604	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Methotrexate—testicular cancer	0.000599	0.000599	CcSEcCtD
Gemifloxacin—Decreased appetite—Epirubicin—testicular cancer	0.000596	0.000596	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000592	0.000592	CcSEcCtD
Gemifloxacin—Fatigue—Epirubicin—testicular cancer	0.000591	0.000591	CcSEcCtD
Gemifloxacin—Constipation—Epirubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Gemifloxacin—Pain—Epirubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Gemifloxacin—Urticaria—Methotrexate—testicular cancer	0.000582	0.000582	CcSEcCtD
Gemifloxacin—Abdominal pain—Methotrexate—testicular cancer	0.000579	0.000579	CcSEcCtD
Gemifloxacin—Body temperature increased—Methotrexate—testicular cancer	0.000579	0.000579	CcSEcCtD
Gemifloxacin—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000578	0.000578	CcSEcCtD
Gemifloxacin—Insomnia—Doxorubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Gemifloxacin—Dyspnoea—Doxorubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Gemifloxacin—Somnolence—Doxorubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Epirubicin—testicular cancer	0.000561	0.000561	CcSEcCtD
Gemifloxacin—Dyspepsia—Doxorubicin—testicular cancer	0.000559	0.000559	CcSEcCtD
Gemifloxacin—Decreased appetite—Doxorubicin—testicular cancer	0.000552	0.000552	CcSEcCtD
Gemifloxacin—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000548	0.000548	CcSEcCtD
Gemifloxacin—Fatigue—Doxorubicin—testicular cancer	0.000547	0.000547	CcSEcCtD
Gemifloxacin—Urticaria—Epirubicin—testicular cancer	0.000545	0.000545	CcSEcCtD
Gemifloxacin—Pain—Doxorubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Gemifloxacin—Constipation—Doxorubicin—testicular cancer	0.000543	0.000543	CcSEcCtD
Gemifloxacin—Abdominal pain—Epirubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Gemifloxacin—Body temperature increased—Epirubicin—testicular cancer	0.000542	0.000542	CcSEcCtD
Gemifloxacin—Asthenia—Methotrexate—testicular cancer	0.000526	0.000526	CcSEcCtD
Gemifloxacin—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000519	0.000519	CcSEcCtD
Gemifloxacin—Pruritus—Methotrexate—testicular cancer	0.000518	0.000518	CcSEcCtD
Gemifloxacin—Urticaria—Doxorubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Gemifloxacin—Abdominal pain—Doxorubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Gemifloxacin—Body temperature increased—Doxorubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Gemifloxacin—Diarrhoea—Methotrexate—testicular cancer	0.000501	0.000501	CcSEcCtD
Gemifloxacin—Asthenia—Epirubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Gemifloxacin—Pruritus—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Gemifloxacin—Dizziness—Methotrexate—testicular cancer	0.000485	0.000485	CcSEcCtD
Gemifloxacin—Diarrhoea—Epirubicin—testicular cancer	0.000469	0.000469	CcSEcCtD
Gemifloxacin—Vomiting—Methotrexate—testicular cancer	0.000466	0.000466	CcSEcCtD
Gemifloxacin—Rash—Methotrexate—testicular cancer	0.000462	0.000462	CcSEcCtD
Gemifloxacin—Dermatitis—Methotrexate—testicular cancer	0.000462	0.000462	CcSEcCtD
Gemifloxacin—Headache—Methotrexate—testicular cancer	0.000459	0.000459	CcSEcCtD
Gemifloxacin—Asthenia—Doxorubicin—testicular cancer	0.000455	0.000455	CcSEcCtD
Gemifloxacin—Dizziness—Epirubicin—testicular cancer	0.000454	0.000454	CcSEcCtD
Gemifloxacin—Pruritus—Doxorubicin—testicular cancer	0.000449	0.000449	CcSEcCtD
Gemifloxacin—Vomiting—Epirubicin—testicular cancer	0.000436	0.000436	CcSEcCtD
Gemifloxacin—Nausea—Methotrexate—testicular cancer	0.000435	0.000435	CcSEcCtD
Gemifloxacin—Diarrhoea—Doxorubicin—testicular cancer	0.000434	0.000434	CcSEcCtD
Gemifloxacin—Rash—Epirubicin—testicular cancer	0.000432	0.000432	CcSEcCtD
Gemifloxacin—Dermatitis—Epirubicin—testicular cancer	0.000432	0.000432	CcSEcCtD
Gemifloxacin—Headache—Epirubicin—testicular cancer	0.00043	0.00043	CcSEcCtD
Gemifloxacin—Dizziness—Doxorubicin—testicular cancer	0.00042	0.00042	CcSEcCtD
Gemifloxacin—Nausea—Epirubicin—testicular cancer	0.000407	0.000407	CcSEcCtD
Gemifloxacin—Vomiting—Doxorubicin—testicular cancer	0.000403	0.000403	CcSEcCtD
Gemifloxacin—Rash—Doxorubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Gemifloxacin—Dermatitis—Doxorubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Gemifloxacin—Headache—Doxorubicin—testicular cancer	0.000398	0.000398	CcSEcCtD
Gemifloxacin—Nausea—Doxorubicin—testicular cancer	0.000377	0.000377	CcSEcCtD
